<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bandres-Ciga S</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>Intramural NIH HHS</funding><funding>NIA NIH HHS</funding><funding>Michael J. Fox Foundation for Parkinson's Research</funding><funding>NINDS NIH HHS</funding><funding>National Institute on Aging</funding><funding>Michael J. Fox Foundation for Parkinson&amp;apos;s Research</funding><pagination>2039-2048</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11568947</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>39(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Commercial genome-wide genotyping arrays have historically neglected coverage of genetic variation across populations.&lt;h4>Objective&lt;/h4>We aimed to create a multi-ancestry genome-wide array that would include a wide range of neuro-specific genetic content to facilitate genetic research in neurological disorders across multiple ancestral groups, fostering diversity and inclusivity in research studies.&lt;h4>Methods&lt;/h4>We developed the Illumina NeuroBooster Array (NBA), a custom high-throughput and cost-effective platform on a backbone of 1,914,934 variants from the Infinium Global Diversity Array and added custom content comprising 95,273 variants associated with more than 70 neurological conditions or traits, and we further tested its performance on more than 2000 patient </pubmed_abstract><journal>Movement disorders : official journal of the Movement Disorder Society</journal><pubmed_title>NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.</pubmed_title><pmcid>PMC11568947</pmcid><funding_grant_id>MJFF‐009421/17483</funding_grant_id><funding_grant_id>ZIA NS003154</funding_grant_id><funding_grant_id>AG000535</funding_grant_id><funding_grant_id>ZIA AG000949</funding_grant_id><funding_grant_id>Z99 AG999999</funding_grant_id><funding_grant_id>MJFF-009421/17483</funding_grant_id><pubmed_authors>Jeff J</pubmed_authors><pubmed_authors>Riley E</pubmed_authors><pubmed_authors>Quinn JP</pubmed_authors><pubmed_authors>Hardy J</pubmed_authors><pubmed_authors>Jabbari E</pubmed_authors><pubmed_authors>Dumanis S</pubmed_authors><pubmed_authors>Hernandez DG</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Blauwendraat C</pubmed_authors><pubmed_authors>Koretsky MJ</pubmed_authors><pubmed_authors>Arepalli S</pubmed_authors><pubmed_authors>Reyes-Palomares A</pubmed_authors><pubmed_authors>Vitale D</pubmed_authors><pubmed_authors>Levine KS</pubmed_authors><pubmed_authors>Faghri F</pubmed_authors><pubmed_authors>Iwaki H</pubmed_authors><pubmed_authors>Crea PW</pubmed_authors><pubmed_authors>Narendra D</pubmed_authors><pubmed_authors>Singleton A</pubmed_authors><pubmed_authors>Houlden H</pubmed_authors><pubmed_authors>Lohmann K</pubmed_authors><pubmed_authors>Majounie E</pubmed_authors><pubmed_authors>Bandres-Ciga S</pubmed_authors><pubmed_authors>Traynor BJ</pubmed_authors><pubmed_authors>Makarious MB</pubmed_authors><pubmed_authors>Klein C</pubmed_authors><pubmed_authors>Global Parkinson's Genetics Program (GP2) and the Center for Alzheimer's and Related Dementias (CARD)</pubmed_authors><pubmed_authors>Schulte C</pubmed_authors><pubmed_authors>Lubbe SJ</pubmed_authors><pubmed_authors>Billingsley K</pubmed_authors><pubmed_authors>Morris HR</pubmed_authors><pubmed_authors>Nalls M</pubmed_authors><pubmed_authors>Leonard H</pubmed_authors><pubmed_authors>Saffie-Awad P</pubmed_authors><pubmed_authors>Scholz SW</pubmed_authors></additional><is_claimable>false</is_claimable><name>NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.</name><description>&lt;h4>Background&lt;/h4>Commercial genome-wide genotyping arrays have historically neglected coverage of genetic variation across populations.&lt;h4>Objective&lt;/h4>We aimed to create a multi-ancestry genome-wide array that would include a wide range of neuro-specific genetic content to facilitate genetic research in neurological disorders across multiple ancestral groups, fostering diversity and inclusivity in research studies.&lt;h4>Methods&lt;/h4>We developed the Illumina NeuroBooster Array (NBA), a custom high-throughput and cost-effective platform on a backbone of 1,914,934 variants from the Infinium Global Diversity Array and added custom content comprising 95,273 variants associated with more than 70 neurological conditions or traits, and we further tested its performance on more than 2000 patient </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-05-15T03:20:35.444Z</modification><creation>2026-05-15T03:12:48.55Z</creation></dates><accession>S-EPMC11568947</accession><cross_references><pubmed>39283294</pubmed><doi>10.1002/mds.29902</doi></cross_references></HashMap>